Novavax Soars
Digest more
Another Breakthrough Summit West in the books, and what an excellent event! We kicked off the day with former FDA head Robert Califf, who stopped by to tell attendees how health secretary Robert F. Kennedy’s hesitance to endorse vaccines is harming the American public.
Novavax (NasdaqGS:NVAX) recently reported a significant financial turnaround for Q1 2025, demonstrating substantial revenue growth and net income improvements. The amending of its collaboration agreement with Takeda offers increased flexibility in vaccine development,